Janku Filip
SEC CIK 1862930 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics, Inc. | Chief Medical Off | 66.0K | — | $1.38M | 10 | 2025-01-02 | 2026-06-30 |
Most active insiders at GLUE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Janku Filip | Chief Medical Off | — | $1.38M |
| 2 | Warmuth Markus | Pres, CEO, Dir | — | $951.1K |
| 3 | Dunn Edmund | Principal Accounting Off | — | $483.1K |
| 4 | Townson Sharon | CSO | — | $423.9K |
| 5 | Manning Anthony M. | Dir | — | $411.2K |
| 6 | Champoux Jennifer | COO | — | $311.3K |
| 7 | Nickson Philip | Chief Business, Legal Off | — | $151.3K |
| 8 | Bowen Matthew | Principal Accounting Off | — | — |
| 9 | Behbahani Ali | Dir | — | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-01 16:57 | 2026-06-30 | GLUE | Monte Rosa Therapeutics, Inc. | Janku Filip | Chief Medical Off | M - OptEx | $13.41 | +5,407 | 66.0K | +9% | +$72.5K |
| DT | 2026-07-01 16:57 | 2026-06-30 | GLUE | Monte Rosa Therapeutics, Inc. | Janku Filip | Chief Medical Off | S - Sale+OE | $24.50 | -5,407 | 60.6K | -8% | -$132.5K |
| DT | 2026-06-30 16:05 | 2026-06-29 | GLUE | Monte Rosa Therapeutics, Inc. | Janku Filip | Chief Medical Off | M - OptEx | $7.56 | +6,000 | 66.0K | +10% | +$45.4K |
| DT | 2026-06-30 16:05 | 2026-06-29 | GLUE | Monte Rosa Therapeutics, Inc. | Janku Filip | Chief Medical Off | S - Sale+OE | $22.95 | -6,000 | 60.0K | -9% | -$137.7K |
| DMT | 2026-06-25 16:05 | 2026-06-23+ | GLUE | Monte Rosa Therapeutics, Inc. | Janku Filip | Chief Medical Off | M - OptEx | $7.56 | +36.0K | 90.0K | +67% | +$272.2K |
| DMT | 2026-06-25 16:05 | 2026-06-23+ | GLUE | Monte Rosa Therapeutics, Inc. | Janku Filip | Chief Medical Off | S - Sale+OE | $21.08 | -41.8K | 60.0K | -41% | -$882.2K |
| 2026-02-24 | 2026-02-23 | GLUE | Monte Rosa Therapeutics, Inc. | Janku Filip | Chief Medical Off | S - Sale | $19.50 | -9,189 | 65.8K | -12% | -$179.2K | |
| D | 2026-01-05 | 2026-01-05 | GLUE | Monte Rosa Therapeutics, Inc. | Janku Filip | Chief Medical Off | S - Sale | $15.17 | -3,155 | 75.0K | -4% | -$47.9K |
| D | 2026-01-05 | 2026-01-02 | GLUE | Monte Rosa Therapeutics, Inc. | Janku Filip | Chief Medical Off | A - Grant | — | +31.0K | 78.2K | +66% | — |
| D | 2025-01-06 | 2025-01-02 | GLUE | Monte Rosa Therapeutics, Inc. | Janku Filip | Chief Medical Off | A - Grant | — | +36.0K | 45.2K | +392% | — |
Purchase Sale Sale after option exercise All abbreviations